Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-000516-24Phase 3Completed
Phase 3 trial of clopidogrel in myocardial infarction (MI), sponsored by Institut für Herzinfarktforschung. Primary endpoint: TIMI 2/3 patency of the infarct-related artery immediately prior to PCI. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-000516-24.